Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Change in Receivables (2023 - 2025)

Ardent Health (ARDT) has 3 years of Change in Receivables data on record, last reported at -$30.8 million in Q3 2025.

  • For Q3 2025, Change in Receivables fell 102.09% year-over-year to -$30.8 million; the TTM value through Sep 2025 reached $20.7 million, down 57.71%, while the annual FY2024 figure was -$40.0 million, 122.09% down from the prior year.
  • Change in Receivables reached -$30.8 million in Q3 2025 per ARDT's latest filing, down from -$16.5 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $126.2 million in Q4 2023 and bottomed at -$60.3 million in Q1 2024.
  • Average Change in Receivables over 3 years is $8.2 million, with a median of -$1.7 million recorded in 2024.
  • The widest YoY moves for Change in Receivables: up 150.91% in 2025, down 875.47% in 2025.
  • A 3-year view of Change in Receivables shows it stood at $126.2 million in 2023, then plummeted by 70.46% to $37.3 million in 2024, then crashed by 182.73% to -$30.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were -$30.8 million in Q3 2025, -$16.5 million in Q2 2025, and $30.7 million in Q1 2025.